Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
La-Z-Boy
LZB
$1.59B
| $24.4M | ﹤0.01% |
760,410
-4,358
| -0.6% | -$157K |
|
1627
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.75B
| $24.4M | ﹤0.01% |
327,228
-8,190
| -2% | -$579K |
|
1628
Northwest Bancshares
NWBI
$2.25B
| $24.4M | ﹤0.01% |
1,924,904
-4,289,715
| -69% | -$54M |
|
1629
First Busey Corp
BUSE
$2.52B
| $24.3M | ﹤0.01% |
963,140
+5,152
| +0.5% | +$130K |
|
|
SILA
1630
DELISTED
Sila Realty Trust
SILA
| $24.3M | ﹤0.01% |
1,027,159
+24,015
| +2% | +$589K |
|
|
JBGS
1631
JBG SMITH
JBGS
$846M
| $24.3M | ﹤0.01% |
1,664,666
-146,720
| -8% | -$2.34M |
|
1632
Dentsply Sirona
XRAY
$2.59B
| $24.3M | ﹤0.01% |
2,096,611
+437,100
| +26% | +$5.45M |
|
1633
G-III Apparel Group
GIII
$1.47B
| $24.3M | ﹤0.01% |
876,980
-50,702
| -5% | -$1.48M |
|
1634
Expro Ltd
XPRO
$1.79B
| $24.2M | ﹤0.01% |
1,390,180
+30,959
| +2% | +$509K |
|
1635
Marriott Vacations Worldwide
VAC
$3.24B
| $24.1M | ﹤0.01% |
370,321
+13,742
| +4% | +$851K |
|
1636
AMERISAFE
AMSF
$569M
| $24M | ﹤0.01% |
720,608
-122,931
| -15% | -$4.43M |
|
1637
Viking Therapeutics
VKTX
$4.04B
| $24M | ﹤0.01% |
736,465
+36,170
| +5% | +$1.16M |
|
1638
10x Genomics
TXG
$5.87B
| $23.9M | ﹤0.01% |
1,127,056
+20,734
| +2% | +$414K |
|
1639
Huron Consulting
HURN
$1.82B
| $23.9M | ﹤0.01% |
187,561
+4,534
| +2% | +$682K |
|
1640
Pitney Bowes
PBI
$2.42B
| $23.9M | ﹤0.01% |
2,160,613
+95,678
| +5% | +$1M |
|
1641
Pathward Financial
CASH
$1.81B
| $23.9M | ﹤0.01% |
267,437
-7,337
| -3% | -$639K |
|
1642
Arcutis Biotherapeutics
ARQT
$3.42B
| $23.9M | ﹤0.01% |
1,012,555
-2,271
| -0.2% | -$58K |
|
1643
IDEAYA Biosciences
IDYA
$3.41B
| $23.8M | ﹤0.01% |
715,527
+894
| +0.1% | +$30K |
|
1644
ManpowerGroup
MAN
$2.39B
| $23.7M | ﹤0.01% |
806,153
+54,343
| +7% | +$1.61M |
|
1645
Albany International
AIN
$2.14B
| $23.7M | ﹤0.01% |
454,513
+22,392
| +5% | +$1.26M |
|
1646
Ashland
ASH
$3.04B
| $23.7M | ﹤0.01% |
425,504
+20,306
| +5% | +$1.2M |
|
1647
Hope Bancorp
HOPE
$1.72B
| $23.7M | ﹤0.01% |
2,117,686
-50,181
| -2% | -$580K |
|
1648
Enterprise Financial Services Corp
EFSC
$2.41B
| $23.6M | ﹤0.01% |
437,070
+1,542
| +0.4% | +$86.9K |
|
1649
Shift4
FOUR
$3.84B
| $23.5M | ﹤0.01% |
537,935
+42,880
| +9% | +$2.37M |
|
1650
First Commonwealth Financial
FCF
$2.12B
| $23.5M | ﹤0.01% |
1,336,538
-3,040,461
| -69% | -$53.6M |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.